Current drugs available for the treatment of primary arterial hypertension (PAH) do not markedly improve survival and novel therapeutic strategies are required. Bone morphogenetic protein receptor ...

Activating the vitamin D receptor shows promise in controlling harmful cell growth linked to pulmonary hypertension ... ribonucleic acid (mRNA) and protein expression of vitamin D receptors ...